Toggle light / dark theme

2 Drugs Show Promise Against Blood Cancers

Ibrutinib, obinutuzumab slowed progression of common leukemia, non-Hodgkin lymphoma.

From the WebMD Archives.

Leave a Comment

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.